Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Valsecchi

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.
Leukemia|February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaT Flohr, A Schrauder, G Cazzaniga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisLars Bossen, Paola Rebora, Francesca Bernuzzi, et al.
Bone Marrow Transplantation|March 5, 1998
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia PediatricaC Messina, M G Valsecchi, M Aricò, et al.
Leukemia|February 13, 2009
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocolV H J Van der Velden, L Corral, M G Valsecchi, et al.
Bone Marrow Transplantation|November 1, 1996
Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/OncologyC Messina, R Rondelli, M G Valsecchi, et al.
Leukemia|September 26, 2017
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|September 16, 2018
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|March 27, 2004
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeN A Heerema, J Harbott, S Galimberti, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicityGuido Cavaletti, David R Cornblath, Ingemar S J Merkies, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.
Leukemia|February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaT Flohr, A Schrauder, G Cazzaniga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisLars Bossen, Paola Rebora, Francesca Bernuzzi, et al.
Bone Marrow Transplantation|March 5, 1998
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia PediatricaC Messina, M G Valsecchi, M Aricò, et al.
Leukemia|February 13, 2009
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocolV H J Van der Velden, L Corral, M G Valsecchi, et al.
Bone Marrow Transplantation|November 1, 1996
Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/OncologyC Messina, R Rondelli, M G Valsecchi, et al.
Leukemia|September 26, 2017
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|September 16, 2018
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|March 27, 2004
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeN A Heerema, J Harbott, S Galimberti, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicityGuido Cavaletti, David R Cornblath, Ingemar S J Merkies, et al.
Pageof 11